Presentation Information
[1P-140]Stimulation of microglial cannabinoid receptor type II ameliorates cognitive decline in Alzheimer's disease mice by controlling neuroinflammation.
*Akira Sobue1,2, Okiru Komine1, Fumito Endo1, Shigeo Murayama3,4, Takashi Saito5, Takaomi Saido6, Koji Yamanaka1 (1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, 2. Medical Interactive Research and Academia Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, 3. Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 4. Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, 5. Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, 6. Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science.)
Keywords:
Alzheimer’s disease,Microglia,neuroinflammation,Astrocyte
Password required to view
Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2022
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2022
